Fatty acid metabolism: opportunities and challenges of traditional Chinese medicine in the treatment of renal fibrosis
Authors:
Open Access
- 21 January 2026
- journal article
- review article
- Published by Springer Nature in Chinese Medicine
- Vol. 21 (1) , 45
Abstract
Renal fibrosis (RF), as a critical pathological process in the progression of chronic kidney disease (CKD) to end-stage renal disease, currently lacks clear and effective reversal measures. Disordered fatty acid metabolism is highly involved in this process. Studies have revealed that molecular crosstalk under fatty acid metabolism dysregulation—such as lipotoxicity, mitochondrial damage, immune inflammation, epigenetics, metabolic reprogramming, and the gut-kidney axis—drives damage to renal tubules, glomeruli, and the interstitium. Therapeutic strategies targeting fatty acid metabolism to ameliorate RF have gradually become a research hotspot, though most current drugs are still in the clinical exploration stage, and the predictive and therapeutic value of many biomarkers remains to be validated. Traditional Chinese Medicine (TCM), with its personalized and modernized approach combining oral administration and external treatments such as acupuncture, enema, and nanodelivery, is increasingly demonstrating advantages in targeting fatty acid metabolism to improve RF. This review outlines the mechanisms and core targets of TCM in regulating fatty acid metabolism to ameliorate RF. The multi-target advantage based on complex components presents an opportunity for TCM to improve RF, though current research still faces challenges such as mechanistic complexity, standardization of TCM, and clinical translation. Future efforts should integrate multi-omics technologies, novel drug delivery systems, and disease-syndrome combination models to advance the development of new integrated Chinese and Western medicine drugs for RF. Graphical abstractKeywords
Funding Information
- National Natural Science Foundation of China (82204886)
- National Natural Science Foundation of China (82474252)
- Natural Science Foundation of Shandong Province (ZR2022QH133)
This publication has 204 references indexed in Scilit:
- Forkhead Box Protein K1 Promotes Chronic Kidney Disease by Driving Glycolysis in Tubular Epithelial CellsAdvanced Science, 2024
- Icariside II prevents kidney fibrosis development in chronic kidney disease by promoting fatty acid oxidationPhytotherapy Research, 2023
- Pharmacokinetics and tissue distribution of five bioactive components in the Corydalis yanhusuo total alkaloids transdermal patch following Shenque acupoint application in rats assessed by ultra‐performance liquid chromatography–tandem mass spectrometryBiomedical Chromatography, 2022
- Lactobacillus acidophilus KBL409 Reduces Kidney Fibrosis via Immune Modulatory Effects in Mice with Chronic Kidney DiseaseMolecular Nutrition & Food Research, 2022
- New Therapies for the Treatment of Renal Fibrosis2019
- Valproic acid attenuates renal fibrosis through the induction of autophagyClinical and Experimental Nephrology, 2016
- Resolvins E1 and D1 inhibit interstitial fibrosis in the obstructed kidney via inhibition of local fibroblast proliferationThe Journal of Pathology, 2012
- Clinical study on treatment of hyperuricaemia by retention enema of Chinese herbal medicine combined with allopurinolChinese Journal of Integrative Medicine, 2009
- Pigment Epithelium-derived Factor is an Angiogenesis and Lipid Regulator that Activates Peroxisome Proliferator-activated Receptor α2008
- CD36 is a novel and potential anti‐fibrogenic target in albumin‐induced renal proximal tubule fibrosisJournal of Cellular Biochemistry, 2007